Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
Apply
FTT-PET & EnhanceAR-Seq
[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step